Evidence map›Paper›PMID 42813368›Full record

ArticleNucleic acids research2026

Type I restriction-modification systems regulate gene expression through DNA topology.

Yasmeen Althari, Yongkui K Chen, Anna Menon, María José Ferrándiz, Renske van Raaphorst, Megan De Ste Croix, Andrew T Ulijasz, David G Glanville, Jan-Willem Veening, Stephen D Bentley and 7 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yasmeen AlthariDepartment of Genetics, Genomics and Cancer Sciences, University of Leicester, Leicester LE1 7RH, United Kingdom.
Yongkui K ChenDepartment of Genetics, Genomics and Cancer Sciences, University of Leicester, Leicester LE1 7RH, United Kingdom.
Anna MenonDipartimento di Farmacia e Biotecnologie, Università di Bologna, Bologna 40126, Italy.
María José FerrándizUnidad de Genética Bacteriana, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28222 Madrid, Spain.ORCID 0000-0003-1428-9506
Renske van RaaphorstUniversity of Lausanne, Department of Fundamental Microbiology, Lausanne 1015, Switzerland.
Megan De Ste CroixDepartment of Genetics, Genomics and Cancer Sciences, University of Leicester, Leicester LE1 7RH, United Kingdom.
Andrew T UlijaszUniversity of Alabama at Birmingham, Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Birmingham, AL 35233, United States.
David G GlanvilleUniversity of Alabama at Birmingham, Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Birmingham, AL 35233, United States.
Jan-Willem VeeningUniversity of Lausanne, Department of Fundamental Microbiology, Lausanne 1015, Switzerland.ORCID 0000-0002-3162-6634
Stephen D BentleyWellcome Sanger Institute, Parasites and Microbes, Hinxton CB10 1RQ, United Kingdom.
Nicholas J CroucherWellcome Sanger Institute, Parasites and Microbes, Hinxton CB10 1RQ, United Kingdom.ORCID 0000-0001-6303-8768
Christopher D BaylissDepartment of Genetics, Genomics and Cancer Sciences, University of Leicester, Leicester LE1 7RH, United Kingdom.
Adela G de la CampaUnidad de Genética Bacteriana, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, 28222 Madrid, Spain.ORCID 0000-0002-3598-2548
Jing-Ren ZhangTsinghua University, School of Basic Medical Sciences, Beijing 100084, China.ORCID 0000-0002-0683-4722
Claudia TrappettiDipartimento di Farmacia e Biotecnologie, Università di Bologna, Bologna 40126, Italy.
Richard D HaighDepartment of Genetics, Genomics and Cancer Sciences, University of Leicester, Leicester LE1 7RH, United Kingdom.
Marco R OggioniDipartimento di Farmacia e Biotecnologie, Università di Bologna, Bologna 40126, Italy.ORCID 0000-0003-4117-793X

Funding

Agencia Estatal de InvestigaciónBiotechnology and Biological Sciences Research Council BB/N002903/1Innovación y UniversidadesItalian Ministry of EducationMedical Research Council MR/M003078/MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases PE00000007MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases PNRR P2022M8KYENational Institute of Allergy and Infectious Diseases AI135060National Institute of Allergy and Infectious Diseases MCIU/AEI/10.13039/501100011033/FEDERNational Institute of Allergy and Infectious Diseases PID2024-157350OB-100NIH HHS
6 · The paper itself

Abstract

This study examines how DNA methylation by both phase-variable and canonical restriction-modification (RM) systems contributes to bacterial gene regulation, using the SpnD39III system of Streptococcus pneumoniae and the prototypical EcoKI system of Escherichia coli. RNA-seq analysis of pneumococcal phase-locked strains expressing individual SpnD39III specificities revealed widespread but promoter-context-dependent differential gene expression associated with methylation. Targeted luciferase reporter assays confirmed that methylation of specific intergenic sites can either activate or repress transcription, validating the transcriptomic observations. Genetic dissection demonstrated that these regulatory effects depend on methyltransferase activity mediated by HsdM and are independent of restriction endonuclease function. These methylation-dependent responses were conserved across pneumococcal strain backgrounds. Mechanistic analyses revealed that methylation alters DNA topology, with methylated plasmids exhibiting reduced negative supercoiling. Consistent with a topology-driven mechanism, modulation of the nucleoid-associated protein HlpA (HU) reshaped promoter responses in a manner dependent on methylation state and promoter topological responsiveness. Extension of these analyses to E. coli showed analogous methylation-dependent regulation by EcoKI, supported by reporter assays, quantitative polymerase chain reaction, RNA-seq, and methylome profiling. Together, these findings demonstrate that RM system-mediated DNA methylation functions as an epigenetic regulator across bacterial species by altering local DNA topology and promoter accessibility, thereby dynamically shaping bacterial gene regulatory networks.

Indexed as

DNA, BacterialDNA MethylationDNA Restriction-Modification EnzymesGene Expression Regulation, BacterialBacterial ProteinsDNA-Binding ProteinsEscherichia coliEscherichia coli ProteinsPromoter Regions, GeneticStreptococcus pneumoniaeTranscription, GeneticBacterial ProteinsDNA, BacterialDNA-Binding ProteinsDNA Restriction-Modification EnzymesEscherichia coli Proteins

Identifiers

PMID42813368
PMCPMC13624659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.